PH27192A - Method for reducing reperfusion injury with imidazol -2-thione-carboxamide - Google Patents

Method for reducing reperfusion injury with imidazol -2-thione-carboxamide Download PDF

Info

Publication number
PH27192A
PH27192A PH37693A PH37693A PH27192A PH 27192 A PH27192 A PH 27192A PH 37693 A PH37693 A PH 37693A PH 37693 A PH37693 A PH 37693A PH 27192 A PH27192 A PH 27192A
Authority
PH
Philippines
Prior art keywords
group
hydrogen
methyl group
methyl
alkyl
Prior art date
Application number
PH37693A
Other languages
English (en)
Inventor
Richard C Dage
Richard A Schnettler
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of PH27192A publication Critical patent/PH27192A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PH37693A 1987-10-19 1988-10-18 Method for reducing reperfusion injury with imidazol -2-thione-carboxamide PH27192A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11014387A 1987-10-19 1987-10-19

Publications (1)

Publication Number Publication Date
PH27192A true PH27192A (en) 1993-04-16

Family

ID=22331436

Family Applications (1)

Application Number Title Priority Date Filing Date
PH37693A PH27192A (en) 1987-10-19 1988-10-18 Method for reducing reperfusion injury with imidazol -2-thione-carboxamide

Country Status (7)

Country Link
EP (1) EP0312960A3 (de)
JP (1) JPH01146820A (de)
KR (1) KR890006232A (de)
AU (1) AU610939B2 (de)
DK (1) DK580288A (de)
PH (1) PH27192A (de)
ZA (1) ZA887662B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA881807B (en) * 1987-03-20 1988-09-05 Merrell Dow Pharmaceuticals Inc. Method for reducing reperfusion injury with imidazol-2-thiones
FR2769838B1 (fr) * 1997-10-16 2000-04-07 Roc Sa Utilisation de derives d'azole pour la preparation d'une composition dermatologique ou cosmetologique
TWI702212B (zh) * 2015-02-09 2020-08-21 德商拜耳作物科學股份有限公司 作為除害劑之經取代的２－硫基咪唑基羧醯胺類

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405628A (en) * 1981-03-05 1983-09-20 Merrell Dow Pharmaceuticals Inc. 4-Pyridylimidazolones and method of use
US4381393A (en) * 1981-05-04 1983-04-26 Merrell Dow Pharmaceuticals Inc. 4-Aminomethyl-5-acyl-1,3-dihydro-2H-imidazol-2-ones

Also Published As

Publication number Publication date
DK580288A (da) 1989-04-20
EP0312960A3 (de) 1990-06-13
ZA887662B (en) 1989-06-28
JPH01146820A (ja) 1989-06-08
DK580288D0 (da) 1988-10-18
KR890006232A (ko) 1989-06-12
AU610939B2 (en) 1991-05-30
AU2376588A (en) 1989-06-01
EP0312960A2 (de) 1989-04-26

Similar Documents

Publication Publication Date Title
DE60003949T2 (de) 5-aryl-1h-1,2,4 triazolverbindungen als cyclooxygenase -2 inhibitoren und dieseenthaltende pharmazeutische zusammensetzungen
DE60009777T2 (de) Verbindung für Behandlung und Vorsorge bei Diabetes
RU2116300C1 (ru) Производные имидазола или их физиологически совместимые соли, способ их получения, средство для снижения высокого давления крови и фармацевтическая композиция для снижения кровяного давления
US5002961A (en) Method for reducing injury with imidazol-2-thionecarboxamides
JP2003508463A (ja) トロンボポイエチン模倣物
KR20010032559A (ko) 위산 분비 억제용 헤테로고리 화합물, 그의 제조 방법 및그의 제약 조성물
KR100354654B1 (ko) 피리미디논 화합물, 이를 함유하는 약제학적 조성물 및이의 제조 방법.
GB2193961A (en) 3-hydroxybenzo(b)thiophene-2-carboxamides
US6465505B1 (en) Benzyl-substituted benzimidazoles
CZ106996A3 (en) Pharmaceutical composition
JP2963476B2 (ja) 腫瘍の転移抑制におけるカスタノスペルミンエステル類
WO2006118329A1 (ja) 安定な乳化組成物
HUT62577A (en) Process for producing imidazolylpropenoic acid derivatives and pharmaceutical compositions comprising same
CS195332B2 (en) Method of producing indazolyl-/4/-oxy-propanolamines
CZ20021251A3 (cs) Derivát imidazolu jako inhibitor fosfodiesterázy VII, jeho pouľití a farmaceutický prostředek, který ho obsahuje
US3836656A (en) Substituted purines as hypolipidemics
CA2913858A1 (en) (+)-5-(3,4-difluorophenyl)-5-[(3-methyl-2-oxopyridin-1(2h)-yl)methyl]imidazolidine-2,4-dione and drug containing same
KR20000035869A (ko) 근조직 변성의 예방 또는 치료제
WO2012130850A1 (de) Gewebetargeting mit onkoziden verbrückten diphenylderivaten zur selektiven behandlung von sexualorgantumoren
AU610939B2 (en) Method for reducing reperfusion injury with imidazol-2- thionecarboxamides
DD210046A5 (de) Verfahren zur herstellung von indolizinderivaten
PT89749B (pt) Processo para a preparacao de alcanoil- e aroil-oxazolonas com accao tonicardiaca
HU192728B (en) Process for producing 4-oxo-pyrido/2,3-d/pyrimidine derivatives and pharmaceutical compositions containing them
KR20150135110A (ko) p-당단백질의 저해제 및 p-당단백질의 기질 약물을 포함하는 약제학적 조성물
CA2150695A1 (en) Antioxidant neuroprotective use of, and method of treatment using, hydroxycarbazole compounds